Jones Financial Companies
ABBV icon

Jones Financial Companies’s AbbVie ABBV Stock Holding History

Jones Financial Companies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$163M Buy
777,405
+491,617
+172% +$109M 0.08% 127
2025
Q4 		$65.3M Buy
285,788
+25,549
+10% +$5.82M 0.04% 146
2025
Q3 		$57.6M Buy
260,239
+31,706
+14% +$6.46M 0.04% 144
2025
Q2 		$41.7M Buy
228,533
+49,581
+28% +$9.21M 0.03% 163
2025
Q1 		$36.8M Buy
178,952
+24,307
+16% +$4.73M 0.03% 147
2024
Q4 		$27.5M Buy
154,645
+49,713
+47% +$9.14M 0.03% 139
2024
Q3 		$20.5M Buy
104,932
+41,905
+66% +$7.82M 0.02% 134
2024
Q2 		$10.8M Buy
63,027
+26,690
+73% +$4.42M 0.01% 143
2024
Q1 		$6.62M Buy
36,337
+4,538
+14% +$782K 0.01% 138
2023
Q4 		$4.93M Buy
31,799
+2,373
+8% +$346K 0.01% 138
2023
Q3 		$4.39M Sell
29,426
-8,975
-23% -$1.32M 0.01% 130
2023
Q2 		$5.17M Buy
38,401
+27,159
+242% +$3.98M 0.01% 125
2023
Q1 		$1.79M Sell
11,242
-366
-3% -$56K ﹤0.01% 164
2022
Q4 		$1.88M Buy
11,608
+1,056
+10% +$162K ﹤0.01% 163
2022
Q3 		$1.42M Sell
10,552
-975
-8% -$140K ﹤0.01% 153
2022
Q2 		$1.77M Buy
11,527
+19
+0.2% +$2.9K ﹤0.01% 142
2022
Q1 		$1.86M Sell
11,508
-157
-1% -$22.8K ﹤0.01% 142
2021
Q4 		$1.58M Sell
11,665
-350
-3% -$41.3K ﹤0.01% 139
2021
Q3 		$1.3M Sell
12,015
-234
-2% -$26.7K ﹤0.01% 142
2021
Q2 		$1.38M Sell
12,249
-2,664
-18% -$300K ﹤0.01% 139
2021
Q1 		$1.61M Buy
14,913
+898
+6% +$96.1K ﹤0.01% 137
2020
Q4 		$1.5M Buy
14,015
+309
+2% +$29.7K ﹤0.01% 135
2020
Q3 		$1.2M Sell
13,706
-5,163
-27% -$486K ﹤0.01% 138
2020
Q2 		$1.85M Sell
18,869
-2,101
-10% -$185K ﹤0.01% 129
2020
Q1 		$1.6M Buy
20,970
+4,070
+24% +$347K ﹤0.01% 131
2019
Q4 		$1.5M Buy
16,900
+849
+5% +$70.5K ﹤0.01% 134
2019
Q3 		$1.22M Sell
16,051
-157
-1% -$10.8K ﹤0.01% 140
2019
Q2 		$1.18M Sell
16,208
-251
-2% -$19.7K ﹤0.01% 140
2019
Q1 		$1.33M Sell
16,459
-2,712
-14% -$222K ﹤0.01% 138
2018
Q4 		$1.77M Sell
19,171
-1,752
-8% -$154K ﹤0.01% 127
2018
Q3 		$1.98M Sell
20,923
-2,174
-9% -$206K ﹤0.01% 127
2018
Q2 		$2.14M Sell
23,097
-16
-0.1% -$1.56K 0.01% 126
2018
Q1 		$2.19M Sell
23,113
-7,744
-25% -$851K 0.01% 125
2017
Q4 		$2.98M Sell
30,857
-2,269
-7% -$214K 0.01% 119
2017
Q3 		$2.94M Sell
33,126
-8,828
-21% -$672K 0.01% 116
2017
Q2 		$3.04M Sell
41,954
-8,521
-17% -$573K 0.01% 117
2017
Q1 		$3.29M Sell
50,475
-18,147
-26% -$1.14M 0.01% 113
2016
Q4 		$4.3M Sell
68,622
-9,395
-12% -$573K 0.02% 100
2016
Q3 		$4.92M Buy
78,017
+177
+0.2% +$11.5K 0.02% 91
2016
Q2 		$4.82M Buy
77,840
+3,852
+5% +$235K 0.02% 86
2016
Q1 		$4.23M Buy
73,988
+16,094
+28% +$897K 0.03% 86
2015
Q4 		$3.43M Buy
57,894
+939
+2% +$54.1K 0.02% 94
2015
Q3 		$3.1M Buy
56,955
+16,116
+39% +$1.05M 0.02% 99
2015
Q2 		$2.74M Buy
40,839
+7,422
+22% +$485K 0.02% 110
2015
Q1 		$1.96M Buy
33,417
+8,571
+34% +$518K 0.01% 124
2014
Q4 		$1.63M Buy
24,846
+6
+0% +$378 0.01% 133
2014
Q3 		$1.44M Buy
24,840
+1,265
+5% +$70.2K 0.01% 138
2014
Q2 		$1.33M Sell
23,575
-2,181
-8% -$114K 0.01% 143
2014
Q1 		$1.32M Buy
25,756
+303
+1% +$15.3K 0.01% 144
2013
Q4 		$1.34M Sell
25,453
-1,399
-5% -$68.8K 0.01% 141
2013
Q3 		$1.2M Buy
26,852
+3,505
+15% +$155K 0.01% 138
2013
Q2 		$965K Buy
+23,347
New +$1.02M 0.01% 144

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jones Financial Companies's ABBV Position: Q1 2026 in Review

Jones Financial Companies increased its AbbVie (ABBV) stake by 172% in Q1 2026, buying an estimated $109M and bringing the position to 777,405 shares worth $163M. The position accounts for 0.08% of the portfolio, ranked #127.

Jones Financial Companies first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Jones Financial Companies held 777,405 shares of AbbVie worth $163M as of Q1 2026.
  • Jones Financial Companies bought 491,617 AbbVie shares in Q1 2026, an estimated $109M.
  • AbbVie made up 0.08% of Jones Financial Companies's portfolio in Q1 2026, its #127 holding.
  • Jones Financial Companies first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.